Levin et al. (88) reported that in vivo microinjection of the glucokinase activator compound A diminished the CRR to acute hypoglycemia, whereas selective downregulation of VMH glucokinase had the opposite effect. This evidence concerns the gene GCK and Hypoglycemia.